| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0003129> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0003130> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0006826> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0027651> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0086692> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0242184> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C0700292> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34486395_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'New England Inflammation and Tissue Protection Institute, Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Halpin-Veszeleiova_Katarina> <https://research.tib.eu/covid-19/entity/Hatfield_Stephen_M>
?:doi	<https://research.tib.eu/covid-19/entity/10.1152/physiol.00010.2021>
?:doi	10.1152/physiol.00010.2021
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Physiology (Bethesda, Md.)
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34486395>
?:pmid	<https://research.tib.eu/covid-19/entity/34486395>
?:pmid	34486395
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34486395>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34486395>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all